Table 1.
The features of the four identified OA subtypes
| Features | C1: GAG metabolic disorder | C2: Collagen metabolic disorder | C3: Activated sensory neurons | C4: Inflammation |
|---|---|---|---|---|
| Molecular features |
PCOL CE2/ACAN ↑ VCAN ↓ GAG metabolic ↑ |
TFGB/COL6A1 ↑ Collagen catabolic ↑ |
GRIK2/GRM7↑ Synapse assembly ↑ |
TMSB4X/CD34 ↑ Immune response ↑ |
| Clinical features | Typical symptom | Severe osteophyte | Younger age of KRS | Apparently narrow joint space |
| Treatment principles | GAG supplement | Collagen supplement | Analgesia | Anti-inflammation |
| Drugs |
Hyaluronic acid Hyaluronic Glucosamine |
Gelatin Hyaluronic collagen Undenatured collagen |
NGF-inhibitor (tanezumab) Acetaminophen Opioids |
NSAIDs Corticosteroids IL-1 inhibitor (canakinumab) TNF-α inhibitor (adalimumab, infliximab, etanercept) |